• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 10, Issue 4
  3. Author

Online ISSN: 2515-8260

Volume10, Issue4

An Observational Study of 0.125% Bupivacaine and 0.1% Bupivacaine with 2mcg/ml Fentanyl to Provide Post-Operative Epidural Analgesia in Patient Undergoing Elective Lower Limb Surgery

    Tanya Dhurwey, Chitra Bansal, Sonam Shrivash, Rajni Thakur

European Journal of Molecular & Clinical Medicine, 2023, Volume 10, Issue 4, Pages 418-424

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Epidural analgesia is the most commonly used technique for inducing postoperative analgesia in lower limb surgeries. Higher concentrations of bupivacaine have been found to be greater motor blockade and it can be minimized by using lower concentrations of bupivacaine (0.1% -0.125%).
Aim: To evaluate the block characteristics, hemodynamic response, and post-operative epidural analgesia between 0.125% Bupivacaine versus 0.1% Bupivacaine in patients scheduled for lower limb surgeries.
Material and Method: This observational study included 60 ASA grade 1 and 2 patients posted for lower limb surgeries. In the study, Group 1 received 0.125% bupivacaine + 2 μg/ml fentanyl, and  Group 2 received 0.1% bupivacaine + 2 μg/ml fentanyl.
Result: The onset of sensory blockade was significantly earlier in patients of Group 1 (15.17 ± 1.46 min vs 19.07 ± 1.85min), and the onset of motor blockade was significantly earlier in patients of Group 1 (28.57 ± 1.71 vs 34.5 ±1.73). Duration of analgesia was longer in group 1 when compared to group 2.  
Conclusion:  0.125% bupivacaine with 2 μg/ml was more effective and provided a longer duration of analgesia as compared to 0.1% bupivacaine with 2 μg/ml for lower limb surgeries. 
Keywords:
    Bupivacaine fentanyl epidural analgesia
  • PDF (368 K)
  • XML
(2023). An Observational Study of 0.125% Bupivacaine and 0.1% Bupivacaine with 2mcg/ml Fentanyl to Provide Post-Operative Epidural Analgesia in Patient Undergoing Elective Lower Limb Surgery. European Journal of Molecular & Clinical Medicine, 10(4), 418-424.
Tanya Dhurwey, Chitra Bansal, Sonam Shrivash, Rajni Thakur. "An Observational Study of 0.125% Bupivacaine and 0.1% Bupivacaine with 2mcg/ml Fentanyl to Provide Post-Operative Epidural Analgesia in Patient Undergoing Elective Lower Limb Surgery". European Journal of Molecular & Clinical Medicine, 10, 4, 2023, 418-424.
(2023). 'An Observational Study of 0.125% Bupivacaine and 0.1% Bupivacaine with 2mcg/ml Fentanyl to Provide Post-Operative Epidural Analgesia in Patient Undergoing Elective Lower Limb Surgery', European Journal of Molecular & Clinical Medicine, 10(4), pp. 418-424.
An Observational Study of 0.125% Bupivacaine and 0.1% Bupivacaine with 2mcg/ml Fentanyl to Provide Post-Operative Epidural Analgesia in Patient Undergoing Elective Lower Limb Surgery. European Journal of Molecular & Clinical Medicine, 2023; 10(4): 418-424.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 25
  • PDF Download: 38
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus